Taylor Wealth Management Partners Zymeworks Inc. Transaction History

Taylor Wealth Management Partners

  • $176 Million
  • Q2 2022

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$6.0 - $16.98 $150,984 - $427,284
-25,164 Closed
0 $0
Q4 2021

Jan 28, 2022
SELL
$15.19 - $29.33 $635,002 - $1.23 Million
-41,804 Reduced 62.42%
25,164 $412,000
Q3 2021

Oct 26, 2021
BUY
$27.35 - $37.28 $18,762 - $25,574
686 Added 1.03%
66,968 $1.95 Million
Q2 2021

Aug 11, 2021
SELL
$26.5 - $38.23 $32,409 - $46,755
-1,223 Reduced 1.81%
66,282 $2.3 Million
Q1 2021

Apr 21, 2021
SELL
$29.83 - $56.81 $31,172 - $59,366
-1,045 Reduced 1.52%
67,505 $2.13 Million
Q4 2020

Feb 02, 2021
SELL
$39.12 - $54.99 $11,775 - $16,551
-301 Reduced 0.44%
68,550 $3.24 Million
Q3 2020

Oct 14, 2020
BUY
$29.21 - $46.58 $6,601 - $10,527
226 Added 0.33%
68,851 $3.21 Million
Q2 2020

Jul 27, 2020
SELL
$33.67 - $40.0 $231,851 - $275,440
-6,886 Reduced 9.12%
68,625 $2.48 Million
Q1 2020

May 04, 2020
SELL
$24.28 - $49.8 $93,478 - $191,730
-3,850 Reduced 4.85%
75,511 $2.68 Million
Q4 2019

Jan 30, 2020
SELL
$24.84 - $45.46 $11,674 - $21,366
-470 Reduced 0.59%
79,361 $3.61 Million
Q3 2019

Oct 17, 2019
SELL
$22.78 - $29.08 $6,720 - $8,578
-295 Reduced 0.37%
79,831 $1.98 Million
Q2 2019

Jul 17, 2019
BUY
$15.0 - $22.49 $1.2 Million - $1.8 Million
80,126 New
80,126 $1.76 Million

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $825M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Taylor Wealth Management Partners Portfolio

Follow Taylor Wealth Management Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Wealth Management Partners, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Wealth Management Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email